Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

MTFB

Motif Bio (MTFB)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:MTFB
DataOraFonteTitoloSimboloCompagnia
23/03/201608:01RNS Non-RegulatoryMotif Bio PLC Motif Bio to present at BIO-Europe SpringLSE:MTFBMotif Bio Plc
14/03/201608:01RNS Non-RegulatoryMotif Bio PLC Appointment of strategic adviserLSE:MTFBMotif Bio Plc
02/03/201610:24Alliance NewsAlliance NewsMotif Bio Says First Patient Dosed In Iclaprim Phase 3 TrialsLSE:MTFBMotif Bio Plc
02/03/201608:00UK RegulatoryMotif Bio PLC First patient dosed in iclaprim Phase 3 trialsLSE:MTFBMotif Bio Plc
23/02/201618:39UK RegulatoryMotif Bio PLC Holding(s) in CompanyLSE:MTFBMotif Bio Plc
22/02/201608:01RNS Non-RegulatoryMotif Bio PLC Webcast on Combating antibiotic resistanceLSE:MTFBMotif Bio Plc
25/01/201608:00UK RegulatoryMotif Bio PLC Appointments of U.S. finance adviser and auditorLSE:MTFBMotif Bio Plc
22/12/201508:00UK RegulatoryMotif Bio PLC Exercise of WarrantsLSE:MTFBMotif Bio Plc
15/12/201510:12Alliance NewsAlliance NewsMotif Bio Says Clinical Trial Supplies For Iclaprim ManufacturedLSE:MTFBMotif Bio Plc
15/12/201508:00UK RegulatoryMotif Bio PLC Iclaprim Clinical Trial Supplies ManufacturedLSE:MTFBMotif Bio Plc
07/12/201508:00RNS Non-RegulatoryMotif Bio PLC Motif selected to present at Biotech ShowcaseLSE:MTFBMotif Bio Plc
24/11/201513:40Alliance NewsAlliance NewsMotif Bio Gets US FDA Agreement For Iclaprim Trial DoseLSE:MTFBMotif Bio Plc
24/11/201508:01UK RegulatoryMotif Bio PLC Receipt of FDA ConcurrenceLSE:MTFBMotif Bio Plc
11/11/201511:58Alliance NewsAlliance NewsMotif Bio Gets Advice On Iclaprim Regulatory ProcessLSE:MTFBMotif Bio Plc
11/11/201508:01UK RegulatoryMotif Bio PLC European Agreement for Iclaprim DevelopmentLSE:MTFBMotif Bio Plc
27/10/201508:00RNS Non-RegulatoryMotif Bio PLC Selected to Present at BIO-Europe 2015LSE:MTFBMotif Bio Plc
21/10/201508:00UK RegulatoryMotif Bio PLC Exercise of OptionsLSE:MTFBMotif Bio Plc
16/10/201509:14Alliance NewsAlliance NewsMotif Bio Signs Clinical Trials Deal With Covance For IclaprimLSE:MTFBMotif Bio Plc
16/10/201508:00UK RegulatoryMotif Bio PLC Leading CRO to Conduct Iclaprim Phase III TrialsLSE:MTFBMotif Bio Plc
13/10/201510:13Alliance NewsAlliance NewsMotif Bio Says Iclaprim Study Data Shown At Infectious Disease WeekLSE:MTFBMotif Bio Plc
13/10/201508:00RNS Non-RegulatoryMotif Bio PLC Results of Two Posters on Iclaprim at ID Week 2015LSE:MTFBMotif Bio Plc
12/10/201517:05Alliance NewsAlliance NewsMotif Bio Issues 53,887 Shares To Former Director (ALLISS)LSE:MTFBMotif Bio Plc
05/10/201517:41UK RegulatoryMotif Bio PLC Directors DealingsLSE:MTFBMotif Bio Plc
29/09/201514:05Alliance NewsAlliance NewsMotif Bio To Present Data From Two Iclaprim Studies At ConferenceLSE:MTFBMotif Bio Plc
29/09/201508:02RNS Non-RegulatoryMotif Bio PLC Presentation of Two Posters on IclaprimLSE:MTFBMotif Bio Plc
23/09/201516:04UK RegulatoryMotif Bio PLC Issue of Shares for Exercised WarrantsLSE:MTFBMotif Bio Plc
03/09/201509:04Alliance NewsAlliance NewsMotif Bio Gets US Fast Track Designation For Iclaprim TreatmentLSE:MTFBMotif Bio Plc
03/09/201508:00UK RegulatoryMotif Bio PLC FDA Grants Fast Track Designation for IclaprimLSE:MTFBMotif Bio Plc
02/09/201508:00RNS Non-RegulatoryMotif Bio PLC Participation at Upcoming Investor EventsLSE:MTFBMotif Bio Plc
02/09/201508:00RNS Non-RegulatoryMotif Bio PLC Appointment of IR AdviserLSE:MTFBMotif Bio Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:MTFB
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network